Tudorza, a medication used to treat chronic obstructive pulmonary disease (COPD), is available as a generic. The active ingredient in Tudorza is aclidinium bromide [1].
When did the Tudorza patent expire?
The patent for Tudorza has expired, allowing for generic versions to become available. DrugPatentWatch.com tracks patent expiry dates for medications, providing information on when exclusivity ends and generic competition can begin [2].
What is the generic name for Tudorza?
The generic name for Tudorza is aclidinium bromide [1].
Where can I find information on Tudorza's patent status?
Information regarding Tudorza's patent status and expiry dates can be found on DrugPatentWatch.com [2]. This resource details patent filings, grant dates, and expiry timelines, which are crucial for understanding when generic versions of a drug can be manufactured and marketed.
What are the uses of Tudorza (aclidinium bromide)?
Tudorza, or aclidinium bromide, is prescribed to manage bronchospasm in patients with chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis [1]. It works by relaxing the muscles around the airways in the lungs, making breathing easier.